Meta-analysis of randomized clinical trials in the era of individual patient data sharing Takuya KawaharaMusashi FukudaMarc Buyse Special Article Open access 12 January 2018 Pages: 403 - 409
Optimal management of immune-related adverse events resulting from treatment with immune checkpoint inhibitors: a review and update Hiroki NagaiManabu Muto Invited Review Article 07 March 2018 Pages: 410 - 420
Time has come for proton and carbon beam therapy Hiroki Shirato Introduction to Review Articles 08 March 2018 Pages: 421 - 422
A systematic review of publications on charged particle therapy for hepatocellular carcinoma Hiroshi IgakiMasashi MizumotoHideyuki Sakurai Invited Review Article 04 September 2017 Pages: 423 - 433
Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis Nobuaki HoshinoRiki GanekoYoshiharu Sakai Review Article 21 December 2017 Pages: 434 - 442
Incidence, risk and prognostic role of anti-epidermal growth factor receptor-induced skin rash in biliary cancer: a meta-analysis Fangqiang WeiDonghun ShinXiujun Cai Review Article 30 December 2017 Pages: 443 - 451
The clinical features of squamous cell lung carcinoma with sensitive EGFR mutations Yuri TaniguchiYoko MatsumotoKazuhiro Usui Original Article 14 February 2018 Pages: 452 - 457
A phase II trial of concurrent chemoradiotherapy with weekly paclitaxel and carboplatin in advanced oesophageal carcinoma Yi XiaYun-hai LiKuai-Le Zhao Original Article Open access 12 February 2018 Pages: 458 - 465
A retrospective analysis of 5-fluorouracil plus cisplatin as first-line chemotherapy in the recent treatment strategy for patients with metastatic or recurrent esophageal squamous cell carcinoma Shuji HiramotoKen KatoNarikazu Boku Original Article 20 January 2018 Pages: 466 - 472
Effect of postoperative radiotherapy on survival in duodenal adenocarcinoma: a propensity score-adjusted analysis of Surveillance, Epidemiology, and End Results database Yu Jin LimKyubo Kim Original Article 19 December 2017 Pages: 473 - 481
Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands Johannes J. M. KwakmanG. VinkM. Koopman Original Article Open access 04 December 2017 Pages: 482 - 489
Phase I study of primary treatment with 5-FU, oxaliplatin, irinotecan, levofolinate, and panitumumab combination chemotherapy in patients with advanced/recurrent colorectal cancer involving the wild-type RAS gene: the JACCRO CC-14 study Hironaga SatakeAkihito TsujiMasashi Fujii Original Article Open access 20 February 2018 Pages: 490 - 496
Characteristics of MUTYH variants in Japanese colorectal polyposis patients Misato TakaoTatsuro YamaguchiHideyuki Ishida Original Article 12 January 2018 Pages: 497 - 503
Differences in histological features and PD-L1 expression between sporadic microsatellite instability and Lynch-syndrome-associated disease in Japanese patients with colorectal cancer Rin YamadaTatsuro YamaguchiShin-ichiro Horiguchi Original Article 11 January 2018 Pages: 504 - 513
Ultrasound-based logistic regression model LR2 versus magnetic resonance imaging for discriminating between benign and malignant adnexal masses: a prospective study Kanane ShimadaKoji MatsumotoAkihiko Sekizawa Original Article 13 December 2017 Pages: 514 - 521
A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB–IIA cervical cancer Xiuzhen XieKun SongBeihua Kong Original Article 03 January 2018 Pages: 522 - 531
Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer Akihiko WakayamaWataru KudakaYoichi Aoki Original Article 23 December 2017 Pages: 532 - 538
Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy Hironori FukudaToshio TakagiKazunari Tanabe Original Article 05 January 2018 Pages: 539 - 546
Effect of everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex: an evaluation based on tumor density Takashi HatanoMahito AtsutaShin Egawa Original Article 18 December 2017 Pages: 547 - 552
Oncological outcomes after cytoreductive nephrectomy for patients with metastatic renal cell carcinoma with inferior vena caval tumor thrombus Hideaki MiyakeTakayuki SugiyamaAtsushi Otsuka Original Article 13 January 2018 Pages: 553 - 558
Efficacy and safety of third-line molecular-targeted therapy in metastatic renal cell carcinoma resistant to first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor and second-line therapy Hiroki IshiharaToshio TakagiKazunari Tanabe Original Article 11 January 2018 Pages: 559 - 567
Comparison of the diagnostic efficacy and perioperative outcomes of limited versus extended pelvic lymphadenectomy during robot-assisted radical prostatectomy: a multi-institutional retrospective study in Japan Shuichi MorizaneMasashi HondaAtsushi Takenaka Original Article 11 December 2017 Pages: 568 - 575
No significant impact of response to prior androgen receptor-axis-targeted agents on the efficacy of subsequent docetaxel in patients with metastatic castration-resistant prostate cancer Hideaki MiyakeYuto MatsushitaAtsushi Otsuka Original Article 23 December 2017 Pages: 576 - 583
Efficacy of docetaxel in castration-resistant prostate cancer patients with intraductal carcinoma of the prostate Akiyuki YamamotoMasashi KatoToyonori Tsuzuki Original Article 03 February 2018 Pages: 584 - 590
Prognostic factors in Chinese patients with prostate cancer receiving primary androgen deprivation therapy: validation of Japan Cancer of the Prostate Risk Assessment (J-CAPRA) score and impacts of pre-existing obesity and diabetes mellitus Meng-Bo HuTian YangQiang Ding Original Article 06 January 2018 Pages: 591 - 598